The IGF system

被引：155

作者：

Annunziata, Marta ^{[1
]}

Granata, Riccarda ^{[1
]}

Ghigo, Ezio ^{[1
]}

机构：

[1] Univ Turin, Div Endocrinol Diabetol & Metab, Dept Internal Med, I-10126 Turin, Italy

来源：

ACTA DIABETOLOGICA | 2011年 / 48卷 / 01期

关键词：

IGF system; Cell proliferation; Insulin analogs; GROWTH-FACTOR-I; SMOOTH-MUSCLE-CELLS; BREAST-CANCER CELLS; REDUCES INSULIN REQUIREMENTS; SOMATOMEDIN-C; MITOGENIC POTENCY; RECEPTOR-BINDING; PLASMA-MEMBRANE; ANALOG GLARGINE; PROTEIN-KINASE;

D O I：

10.1007/s00592-010-0227-z

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The insulin-like growth factor (IGF) system plays essential role in the regulation of cell growth, proliferation and survival and affects nearly every organ system in the body. IGF-I, which has a high structural similarity to insulin, exerts growth-promoting effects, influences glucose metabolism and has neuroprotective and cardioprotective effects, partly because of its cell-proliferative and antiapoptotic properties. Aberrations in the IGF system may associate with various pathological conditions, including cancer. Insulin and its synthetic analogs are known to possess IGF-IR binding affinity, and concern has been raised about their mitogenic potential in humans. The present review summarizes the main aspects of the IGF system biology and the interactions among IGF-I, insulin, insulin analogs and their receptors.

引用

页码：1 / 9

页数：9

共 119 条

[1] Insulin-like growth factor-I and cognitive function in healthy older men [J].

Aleman, A ;

Verhaar, HJJ ;

De Haan, EHF ;

De Vries, WR ;

Samson, MM ;

Drent, ML ;

Van der Veen, EA ;

Koppeschaar, HPF .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (02) :471-475

[2] The role of IGF-system in vascular insulin resistance [J].

Arnqvist, H. J. .

HORMONE AND METABOLIC RESEARCH, 2008, 40 (09) :588-592

[3] Growth promoting and metabolic activity of the human insulin analogue [Gly(A21),Arg(B31),Arg(B32)]insulin (HOE 901) in muscle cells [J].

Bahr, M ;

Kolter, T ;

Seipke, G ;

Eckel, J .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 320 (2-3) :259-265

[4]

BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O

[5] IGF-1 receptor as an alternative receptor for metabolic signaling in insulin receptor-deficient muscle cells [J].

Baudry, A ;

Lamothe, B ;

Bucchini, D ;

Jami, J ;

Montarras, D ;

Pinset, C ;

Joshi, RL .

FEBS LETTERS, 2001, 488 (03) :174-178

[6]

Baxter R C, 1989, Prog Growth Factor Res, V1, P49, DOI 10.1016/0955-2235(89)90041-0

[7] Insulin Receptor Isoforms and Insulin Receptor/Insulin-Like Growth Factor Receptor Hybrids in Physiology and Disease [J].

Belfiore, Antonino ;

Frasca, Francesco ;

Pandini, Giusepe ;

Sciacca, Laura ;

Vigneri, Riccardo .

ENDOCRINE REVIEWS, 2009, 30 (06) :586-623

[8] The long acting human insulin analog HOE 901:: Characteristics of insulin signalling in comparison to Asp(B10) and regular insulin [J].

Berti, L ;

Kellerer, M ;

Bossenmaier, B ;

Seffer, E ;

Seipke, G ;

Häring, HU .

HORMONE AND METABOLIC RESEARCH, 1998, 30 (03) :123-129

[9] SOMATOMEDIN RECEPTOR OF HUMAN-PLACENTA - SOLUBILIZATION, PHOTOLABELING, PARTIAL-PURIFICATION, AND COMPARISON WITH INSULIN-RECEPTOR [J].

BHAUMICK, B ;

BALA, RM ;

HOLLENBERG, MD .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (07) :4279-4283

[10] INSULIN-LIKE GROWTH-FACTOR - MODEL FOR TERTIARY STRUCTURE ACCOUNTING FOR IMMUNOREACTIVITY AND RECEPTOR-BINDING [J].

BLUNDELL, TL ;

BEDARKAR, S ;

RINDERKNECHT, E ;

HUMBEL, RE .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (01) :180-184

← 1 2 3 4 5 6 7 8 9 10 →